tiprankstipranks
Advanced Oncotherapy PLC (GB:AVO)
LSE:AVO

Advanced Oncotherapy (AVO) Share Price & Analysis

2 Followers

AVO Stock Chart & Stats

Day’s Range0p - 0p
52-Week Range1.75p - 8.70p
Previous Close1.75p
Volume0.00
Average Volume (3M)N/A
Market Cap
£9.50M
Enterprise Value66.73M
Total Cash (Recent Filing)£2.51M
Total Debt (Recent Filing)£59.74M
Price to Earnings (P/E)N/A
Beta-0.07
Jun 26, 2024
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding537,481,209
10 Day Avg. Volume264,856
30 Day Avg. VolumeN/A
Standard Deviation2.74
R-Squared0.02
Alpha0.34
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0

Financials

Annual

Options Prices

Currently, No data available
---

Ownership Overview

17.77%0.00%0.00%82.23%
17.77%
Insiders
0.00% Other Institutional Investors
82.23% Public Companies and
Individual Investors

AVO FAQ

What was Advanced Oncotherapy PLC’s price range in the past 12 months?
Advanced Oncotherapy PLC lowest share price was 1.75p and its highest was 8.70p in the past 12 months.
    What is Advanced Oncotherapy PLC’s market cap?
    Currently, no data Available
    When is Advanced Oncotherapy PLC’s upcoming earnings report date?
    Advanced Oncotherapy PLC’s upcoming earnings report date is Jun 26, 2024 which is in 75 days.
      How were Advanced Oncotherapy PLC’s earnings last quarter?
      Currently, no data Available
      Is Advanced Oncotherapy PLC overvalued?
      According to Wall Street analysts Advanced Oncotherapy PLC’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
        Does Advanced Oncotherapy PLC pay dividends?
        Advanced Oncotherapy PLC does not currently pay dividends.
        What is Advanced Oncotherapy PLC’s EPS estimate?
        Advanced Oncotherapy PLC’s EPS estimate for its next earnings report is not yet available.
        How many shares outstanding does Advanced Oncotherapy PLC have?
        Advanced Oncotherapy PLC has 542,573,850 shares outstanding.
          What happened to Advanced Oncotherapy PLC’s price movement after its last earnings report?
          Currently, no data Available
          Which hedge fund is a major shareholder of Advanced Oncotherapy PLC?
          Currently, no hedge funds are holding shares in GB:AVO
          ---

          Advanced Oncotherapy Stock Smart Score

          Company Description

          Advanced Oncotherapy PLC

          Advanced Oncotherapy PLC is active in the healthcare domain in the United Kingdom. As a medical care provider, its focus is to develop technologies to maximize the destructive effect of radiation on tumors whilst minimizing damage to healthy tissues. It develops an affordable proton-based radiotherapy system, using innovative and clinically effective technology, thereby contributing in curing critical unmet conditions. The company's only business segments being Proton Therapy.
          ---
          Similar Stocks
          Company
          Price & Change
          Follow
          Avacta Group plc
          Abingdon Health PLC
          Belluscura PLC
          Popular Stocks
          ---
          What's Included in PREMIUM?
          Make informed decisions based on Top Analysts' activity
          Know what industry insiders are buying
          Get actionable alerts from top Wall Street Analysts
          Find out before anyone else which stock is going to shoot up
          Get powerful stock screeners & detailed portfolio analysis